SIRT1 and lung carcinoma: In this study, we showed that the NSAIDs celecoxib and sulindac suppress lung cancer migration and invasion by inhibiting TGF-β1-induced EMT, and that NSAID-induced EMT inhibition in lung cancer may be attributed, at least partially, to a SIRT1-mediated pathway.